ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.
ANALYSIS: As a dispute over potential liability for bursting pipes in Australia escalates, there are still big holes in each side’s arguments.
ANALYSIS: It’s time our courts and lawyers paid more attention to understanding events beyond our shores.
ANALYSIS: Regulatory documents released under the Official Information Act point to a lack of investigative vigour.
ANALYSIS: Comprehensive not guilty verdicts on fraud charges may be seen as a vindication of the insurer’s management and a condemnation of the RBNZ. Not so fast.
ANALYSIS: This week’s disclosure of contractual strife with big customer A2 Milk has added to the perception of risk.
ANALYSIS: Listed tech company’s deeply discounted rights issue looks weird, as does its rejection by takeover bidder Volaris, but there may be a simple explanation.
ANALYSIS: As shown by casino operator SkyCity’s regulatory strife, there is a practical as well as an ethical issue for investors.
ANALYSIS: After 150 years, the institution is failing in its primary purpose and short-changing its own customers.
Fletcher Building may be optimistic about a piping problem in Australia but the market has good reason to be wary.
